Friday, April 23, 2010

FR1

Four Hours of Dry Eye Information in Sixty Minutes

Bill Townsend, OD

COPE #18243-AS

This presentation discusses ocular surface disease- specifically, the physiology of dry eye, its diagnosis and treatment.

FR2

Post Surgical Contact Lens Fitting

Jenny Smythe, OD

COPE #21007-CL

After setting the stage with corneal topography and basic RGP fitting goals, fitting pearls for the post-surgical cornea are highlighted through a series of examples of both the routine post-surgical case as well as more interesting and complex fitting challenges.

FR3

Megatrends in Medicine

Bruce Onofrey, OD

COPE #26107-SD

With virtually every patient encounter, optometrists are reminded of just how intertwined vision is with systemic well being. It is for precisely this reason that primary eye care providers be well versed on trends in systemic medicine. This course addresses certain megatrends in medicine and how they affect eye care. Our emphasis is on new diagostic criteria for disease detection, contemporary treatment protocols, and their ramifications for optometry.

FR4

Everyday Eye Health: Women at Risk

Diana Shechtman, OD

COPE #24764-GO

Healthy Sight Consultation (HSC), in providing a blueprint to achieve Healthy Sight, places a high priority on those individuals at increased risk for vision-threatening ocular diseases. It has been estimated that women represent a disproportionate two-thirds of all blind and visually-impaired people in the U.S. Certain eye diseases--including trachoma, dry eye states, and autoimmune disorders--are more common in females than males, and since women generally live longer than men, they are more likely to develop age-related eye diseases like cataract and macular degeneration. These facts, along with the unfortunate fact that females generally have less access to medical and eye care than males, make women an important target group for HSC.

FR5

Thyroid Disease and the Eye: What We Must Know

Bill Townsend, OD

COPE #23451-SD

This presentation addresses the normal anatomy and functions of the thyroid and describes systemic thyroid dysfunction. The remainder of the lecture focuses on the OD’s role in diagnosis and management of thyroid-associated ocular disease alerting health care providers to the presence of undiagnosed thyroid disease.

FR6

The Must-Have Systemic Medications

Bruce Onofrey, OD

COPE #26118-PH

This course will discuss proper selection, dosing and monitoring of topical therapies to safely and effectively treat patients. The course also will address and provide clinical examples of the concept of “drug of choice” for a variety of ocular disorders that will include infection, allergy, inflammation, dry eye and pain.

FR7

Update on Diagnosis and Management of AMD

Steven Ferrucci, OD & Diana Shechtman, OD

COPE #24753-PS

AMD remains one of the most common causes of vision loss in the geriatric population. There have been some exciting new treatments that for the first time offer hope for our patients. This course will discuss these new treatment including the antiVEGF drugs lucentis and Avastin as well as others in the pipeline.

Lunch in Exhibit Hall

FR8

GPS: Roadmap into Retinal Disease

Bill Townsend, OD & Diana Shechtman, OD

COPE PENDING

Several retinal disorders with similar histological features occur in both the posterior and peripheral retina. An example would be retinoschisis, which occurs in both central (juvenile) and peripheral (degenerative) forms. In this course we discuss this and a number of other retinal conditions that may share a similar pathophysiology but vary drastically in their clinical presentation based on their location.

FR9

Pharmaceutical Update: Management of Ocular Pain and Inflammation

Bruce Onofrey, OD

COPE #25811-PH

A complete review of the indications, contraindications, side effects and dosages of major analgesic/anti-inflammatory agents will be given. Drug selection criteria of both narcotic and non-narcotic medications are discussed. The use of steroids VS NSAIDS is covered in detail.

FR10

Diabetes: Treatment and Management

Steve Ferrucci, OD

COPE PENDING

This course provides an introduction to diabetes, with an emphasis on Type 2. The systemic medications used for the treatment of diabetes are reviewed, with some of the common side efffects. The second part of the lecture is a review of the newest diabetic retinopathy classification and management recommendations.

FR11

Challenging Macular Cases: You Make The Call

Steve Ferrucci, OD & Diana Shechtman, OD

COPE #22862-PS

This lecture will cover macular disease topics, which may pose a challenge to the optometric physician. Case presentation format will be use to introduce the particular topics. Cases discussed will include clinical presentation, management options, as well as, clinical pearls. Audience participation with regards to diagnosis is highly encouraged.

FR12

Interactive Grand Rounds: A Tale of Two Doctors

Bruce Onofrey, OD & Bill Townsend, OD

COPE #25237-AS

This presentation addresses actual anterior segment cases encountered in private practice setting and at the VAMC where the lecturer served as a consultant for 11 years. The audience is strongly encouraged to participate in decision making regarding the diagnosis and management of each case.

FR13

Glaucoma: New Technologies in Structure and Function

Michael Chaglasian, OD

COPE #21777-GL

This course presents the current approaches to the diagnosis and management of glaucoma with widely available technology. Integrating this data into a treatment plan can be complex and confusing. A stepwise approach with case presentations and examples will guide the practitioner to a better utilization of technology.